PTPRB | Protein tyrosine phosphatase, receptor type, B | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
PTPRC | Protein tyrosine phosphatase, receptor type, C | Cancer-related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
RB1 | Retinoblastoma 1 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
RECQL4 | RecQ protein-like 4 | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
RNF43 | Ring finger protein 43 | Cancer-related genes Predicted membrane proteins
| | | | | Mixed |
SDHD | Succinate dehydrogenase complex, subunit D, integral membrane protein | Cancer-related genes Citric acid cycle related proteins Disease related genes FDA approved drug targets Mitochondrial proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
SETD2 | SET domain containing 2 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
SMARCA4 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
SMARCB1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
STAG2 | Stromal antigen 2 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
STK11 | Serine/threonine kinase 11 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
SUFU | Suppressor of fused homolog (Drosophila) | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
TSC1 | Tuberous sclerosis 1 | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
TSC2 | Tuberous sclerosis 2 | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
UBR5 | Ubiquitin protein ligase E3 component n-recognin 5 | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
VHL | Von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
WAS | Wiskott-Aldrich syndrome | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
WRN | Werner syndrome, RecQ helicase-like | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Mixed |
WT1 | Wilms tumor 1 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
XPA | Xeroderma pigmentosum, complementation group A | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
XPC | Xeroderma pigmentosum, complementation group C | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ZRSR2 | Zinc finger (CCCH type), RNA-binding motif and serine/arginine rich 2 | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |